WO2003105873A1 - Tailor-made preparation and process for producing the same - Google Patents

Tailor-made preparation and process for producing the same Download PDF

Info

Publication number
WO2003105873A1
WO2003105873A1 PCT/JP2002/005901 JP0205901W WO03105873A1 WO 2003105873 A1 WO2003105873 A1 WO 2003105873A1 JP 0205901 W JP0205901 W JP 0205901W WO 03105873 A1 WO03105873 A1 WO 03105873A1
Authority
WO
WIPO (PCT)
Prior art keywords
individual
chicken
meat
tiller
ostrich
Prior art date
Application number
PCT/JP2002/005901
Other languages
French (fr)
Japanese (ja)
Inventor
正俊 深尾
Original Assignee
株式会社 トーカイビケン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 トーカイビケン filed Critical 株式会社 トーカイビケン
Priority to AU2002313212A priority Critical patent/AU2002313212A1/en
Priority to PCT/JP2002/005901 priority patent/WO2003105873A1/en
Publication of WO2003105873A1 publication Critical patent/WO2003105873A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Definitions

  • the present invention relates to tiller-made preparations such as health food preparations and pharmaceutical preparations for the purpose of curing chronic diseases such as cancer, diabetes mellitus and allergy and improving symptoms, and to a method for producing the same.
  • the present invention relates to a tiller-made preparation configured to exert a corresponding health promotion effect and a method for producing the same. More specifically, a tiller-med product obtained by using the biological reactions of healthy osseous chickens to produce active ingredients that exert a health-enhancing effect corresponding to the individual's physiological condition, and then processing the ingredients. And its production method.
  • Conventional health food preparations include food materials that contain high levels of health-promoting substances such as vitamins, minerals, and antioxidants, or foods made of natural products that have been confirmed to have statistically significant health-promoting effects. Material is contained. Further, conventional pharmaceutical preparations contain a drug having a pharmacological effect. Health food preparations and pharmaceutical preparations exert certain health-enhancing or pharmacological effects on those who take them.
  • An object of the present invention is to provide a tiller-made preparation which can be easily taken without side effects and easily exerts a health promotion effect corresponding to an individual's physiological condition, and a method for producing the same.
  • a tiller-made preparation exhibiting a health promotion effect corresponding to an individual's physiological condition.
  • the formulation inoculates a carrier of the physiological information of the individual into the ostrich chicken, and after breeding for a predetermined period, the meat of the ostrich chicken.
  • the carrier is used to inoculate osseous chickens transdermally or orally, with individual serum and urine Preferably, there is only one.
  • the predetermined time period is between 30 and 75 days.
  • the tiller maid preparation is orally ingested from 8 to 12 g of dry meat once a week for at least 10 weeks per adult.
  • the present invention further provides a method for producing a tiller-made preparation.
  • the method includes a step of inoculating a carrier of physiological information of an individual into a ostrich, and a step of drying and crushing the meat of the ostrich bred for a predetermined period of time at 50 ° C or less.
  • FIG. 1 is a graph showing the change in fasting blood glucose level of male A who took the tiller maid preparation of the present invention.
  • the inventor of the present application has found that a tiller-made preparation produced using a crow bone chicken has a remarkable pharmacological action, and has completed the present invention.
  • Cousin chickens are slightly smaller varieties than common chickens.
  • the whole body of the ostrich is covered with silky, thin and soft feathers.
  • the face, skin, meat, bones, and internal organs of the crow bone chicken are dark purple.
  • the earlobe is cobalt blue.
  • the male has a walnut crown on the head, and the female has a fine crown.
  • Cousin chicken is described in old Chinese literature as a medicine for longevity or as a court meal for treating illness and beauty.
  • crow's-bone chickens have been preserved for thousands of years because of their excellent medicinal properties, and have been loved by many people.
  • crow bone chicken is known to have various pharmacological actions such as anticancer action, and is used as a raw material for herbal medicine.
  • the pharmacological effects of osseous chicken have not been studied in detail.
  • Tillermaid preparations contain dried meat of crow bone chicken that reflects the physiological condition (pathological condition) of a particular individual.
  • Tillermade preparations exert a health-promoting or healing effect corresponding to the physiological or pathological condition of the individual.
  • Tiller-made products are health food or pharmaceutical products that are manufactured and used exclusively for a particular individual. That is, a tailor-made product is entrusted and ordered by a specific individual to a manufacturer for the manufacture of a personalized product, and the manufacturer manufactures the product based on the order and provides it to that person. It is a custom-made product.
  • the dried meat of the crow bone chicken is obtained as follows. First, a carrier of physiological information of a specific individual is inoculated into a living body of a crow bone chicken and bred for a predetermined period. By slaughtering the ostrich chicken, the meat is dried and crushed (crushed) at a temperature of 50 ° C or less to obtain a dry powder or a granular material that can be easily ingested. In addition, as the meat of the crow bone chicken, at least one selected from the group consisting of peach meat, breast meat, and fillet meat is preferable.
  • the tailor-made preparation may be in the form of powdered dry meat of osseous chicken itself or in a form that can be orally ingested such as tablets, capsules and drinks prepared by processing the dried meat according to a conventional method.
  • Carriers of physiological information of a particular individual include parts of the body (tissue), secretions or excretions carrying information on the physiological condition of that individual.
  • Preferred carriers are serum or urine because they carry more physiological information about their health and are easier to collect.
  • the carrier contains information about the individual's physiological condition (pathology), such as immunoglobulins (antibodies), non-self antigens bound to class I or class II human leukocyte antigen (HLA), toxins, or appropriate amounts.
  • Non-hormones serum cholesterol, neutral fat, blood sugar, GOT (glutamate oxaloacetat e transaminase), GP ⁇ glutamate pyruvate transaminase), ⁇ -GTP (glutamyl transpeptidase), urinary protein, urinary occult blood, urinary bran, urobilinogen Etc. are included in various forms.
  • GOT glutamate oxaloacetat e transaminase
  • GP ⁇ glutamate pyruvate transaminase glutamyl transpeptidase
  • urinary protein urinary occult blood, urinary bran, urobilinogen Etc.
  • the carrier should be collected when the patient is in good physical condition, avoiding stress such as overwork, lack of sleep, and hangover. Is preferred.
  • the carrier is preferably inoculated into adult ostrich chickens at the age of 180 days or older, and inoculated into middle-aged ostrich chickens at the age of 180 to 300 days after birth, where biological reactions are active. More preferred. Sex is not asked. Furthermore, in order to reflect the physiological information carried on the carrier sharply and without omission, it is preferable to inoculate healthy breeding chickens in an environment in which stress is minimized. Environments with reduced stress include, for example, an environment where organic feed and water are provided without pesticides and without antibiotics or sulfa drugs, an environment where seaweed containing high alginate is fed, or Environments with low environmental pollution, noise, and interference from other species. Also, pure crow bones, not hybrids Chicken is preferred.
  • the breeding period from inoculation of the carrier to the osseous chicken to slaughter is preferably 30 to 75 days after the start of the inoculation (from the start of the first inoculation), more preferably 35 to 75 days. 70 days, more preferably 35 to 60 days. If the breeding period is less than 30 days, the active ingredient having a health-promoting effect that reflects the physiological state (pathological state) of a specific individual in the living body of the crow bone chicken (probably an antibody-like substance ) May not be produced sufficiently. On the other hand, if it exceeds 75 days, the amount of the active ingredient may be significantly reduced. In the case of inoculation by oral administration, the breeding period may be extended to about 90 days because it takes a long time to complete all inoculations. In this case, a good tailor-made product may be obtained.
  • Meat collected from slaughtered poultry chicken is dried and crushed to be processed into powdered or granular dried poultry meat of poultry chicken. .
  • all the steps must be carried out at a temperature of 50 ° C or less, and the denaturation of the protein is effective.
  • the heating is performed at a temperature of 40 ° C. or less in order to suppress the temperature to 40 ° C.
  • the drying step is preferably performed by a freeze-drying (freeze-drying) method in order to more effectively suppress denaturation and deactivation of the active ingredient.
  • the dried meat pieces are processed into various forms such as tablets, capsules, drinks and the like, preferably stored in a refrigerator or a freezer, and orally ingested by the client as a tiller-made preparation at appropriate times.
  • Tillermaid Seika [) is orally ingested about 10 g (8 to 12 g) of dry meat of crow bone chicken once a week (preferably every 7 days) per adult. It is most preferably taken for 10 weeks or more, more preferably for 10 to 20 weeks continuously.
  • the Tiller Made preparation When taken for the purpose of healing or ameliorating the symptoms of a specific disease, the Tiller Made preparation is used for the average replacement cycle of the cells in the organs or tissues that make up the disease or condition (physiological changes). It is preferable to take the drug continuously for a period corresponding to (cell life) or an integral multiple thereof. For example, if you have diabetes, you should take it continuously for a period corresponding to the average cell life of the insulin-producing cells of the kidney, and you should take it for twice the life of the cell Is more preferred.
  • Tillermaid preparations contain dried meat from ostrich chicken that reflects the physiological condition of a particular individual. Dried meat of the ostrich chicken is inoculated with a carrier of physiological information of a specific individual to a healthy ostrich chicken so as not to harm the health, and slaughtered after bred for a predetermined period while maintaining the health of the ostrich chicken. It is obtained by drying and crushing the raw meat at a temperature of 50 ° C or less. Tiller-made preparations can be easily ingested because they are made from healthy bovine chicken meat, and there is no risk of side effects such as phytotoxicity if ingested too much.
  • Dried meat of ostrich chicken has a long-lasting, pharmacological action that is effective for everyone and has been specially produced using the biological reactions of healthy ostrich chicken. Contains sexual components. For this reason, the Tillermaid formulation can exert a synergistic effect of promoting health on specific individuals. In addition, tiller maid preparations contain high concentrations of proteins and amino acids, so that metabolism is activated. It can also exert a health promotion effect.
  • the active ingredient is produced individually based on the carrier of the physiological information of a specific individual, the physiological condition of the individual is reflected to the smallest detail, and the physiological condition of the person The health promotion effect corresponding to can be exhibited.
  • multiple types of physiological information are carried on the carrier and are multifaceted (comprehensive). Therefore, a multifaceted health-promoting effect can be obtained with the Tillermade formulation. If a specific individual is suffering from a disease such as a chronic disease, the carrier will contain physiological information about the person's pathological condition, and will have a significant healing effect or improvement effect on the disease. Can be demonstrated.
  • the tiller-made preparation of the present embodiment is not limited to the effect of improving a single symptom as in conventional health food preparations and pharmaceutical preparations, and exhibits a multifaceted improvement effect for a plurality of symptoms. It can exhibit excellent efficacy as a panacea.
  • Tiller-made products are manufactured by inoculating the serum or urine of a specific individual into bovine hens, so that a multifaceted health promotion effect corresponding to the physiological condition of a specific individual is easily and reliably achieved. Can be obtained.
  • serum and urine provide detailed and detailed physiological information on the physiological and pathological states of the individual, as evidenced by the fact that there are many types of diseases that are medically detected in medical examinations. It is definitely included. For this reason, by producing dried meat of ostrich chicken using such a carrier carrying useful physiological information, the health condition of the individual and the It is easy to obtain an extremely multifaceted and accurate effect on the improvement of the pathological condition.
  • the biological defense reaction represented by the immune reaction shows the maximum activity at the peak 30 to 75 days from the start of the reaction, and the bovine chicken in the peak state is collected and used. By doing so, it is possible to obtain the maximum health promotion effect significantly easily. Furthermore, by drying before the activity is lost, the physicochemical and biological effects on the active ingredient can be minimized, so that the activity of the active ingredient can be continuously maintained for a long period of time. This makes it easier to hold them.
  • Tillermade products are designed to take 8 to 12 g of dry meat of crow boned chicken once per week per adult, and to be taken continuously for at least 10 weeks, thereby promoting health. The effect can be significantly increased.
  • the method of ingesting the tiller maid preparation is the most efficient and aggressive way to elicit the biological response of the administered individual, similar to when the carrier of the physiological information is orally administered to the ostrich. Therefore, it is optimal for enhancing health promotion effects.
  • Serum from a Japanese male A (59 years old, weighing 60 kg) suffering from mild adult-type diabetes and mild chronic allergic monodermatitis was collected.
  • the fasting blood glucose level of Male A has been around 150 to 20 Omg / d1 continuously for several years.
  • Male A took 6 units of insulin before and during the test before and during the test, and took 2.5 mg eudalcon (Eu glucon: product name) 2.5 mg tablets after breakfast and 1 tablet after dinner .
  • Three 180- to 250-day-old healthy ostrich chickens kept in a stress-reduced environment were injected intravenously with 1 ml of serum. After 30 days, three hens were slaughtered and peaches, mune and fillet were collected in a sanitary manner.
  • the minced raw meat was freeze-dried with a freeze dryer.
  • the lyophilized chicken was carefully ground in a food processor at 50 ° C or less.
  • Tiller-made preparations were manufactured by bagging 10 g of the ground meat pieces. Keep the tiller maid product in the freezer was tubed.
  • Male A continuously ingested one bag of tillermaid once a week.
  • the fasting blood glucose level of male A was measured daily to determine the weekly average (monthly average before the first week of administration). As shown in Figure 1, the blood glucose level of male A declined steadily over time, with fasting blood glucose levels of 11 Omg / d1 at week 10 and 11 at week 11.
  • the dose was 2 mg Zdl and at week 12 was 102 mg Zd1.
  • subjective symptoms of Male A gradually and clearly subsided. Male A also felt reduced physical fatigue.
  • the serum of a particular individual may be transdermally administered to the ostrich
  • the urine of the same individual may be orally administered to the ostrich at the same time or at a different time.
  • Blood may be used as a carrier for physiological information. In this case, a healing effect on diseases of blood cells or blood coagulation can be exerted.
  • a specific component may be separated and purified from serum or urine, and only the separated component may be inoculated into ostriches.
  • a body tissue cancer cell or the like collected by a biopsy may be used as a carrier for physiological information. In these cases, a highly specific healing effect on the target disease can be exerted by narrowing down the carriers of the physiological information in advance.
  • the dried product in addition to the dried meat of the osseous chicken, various components derived from the osseous chicken (eg, eggs (egg yolk, egg white, eggshell, eggshell membranes), internal organs (heart and liver), epidermis, bone , Blood, cockscomb, etc.).
  • the dried product is preferably manufactured by drying and pulverizing at 50 ° C. or lower.

Abstract

A tailor-made preparation which is constituted so that it can be easily taken without any side effect and easily establish an effect of improving one’s health in appropriate manner for individual physiological state. The tailor-made preparation contains dry black chicken meat concerning the individual physiological state. This dry black chicken meat is produced by inoculating a black chicken bird with a serum or urine carrying the data of the individual physiological state, feeding the bird for 30 to 75 days, and drying and grinding the meat at 50°C or below. The tailor-made preparation is orally administered continuously for 10 weeks or longer in such a manner as to give a dose of the dry black chicken of 8 to 12 g/week for an adult.

Description

明細書  Specification
ティラーメイ ド製剤及びその製造方法 Tillermade preparation and method for producing the same
[技術分野]  [Technical field]
本発明は、 癌、 糖尿病、 アレルギー等の慢性疾患の治癒や症状の改善を目的と した健康食品製剤や医薬品製剤等のティラーメイド製剤及びその製造方法に関し 、 より詳しくは、 各個人の生理状態に対応した健康増進効果を発揮するように構 成されたティラーメイド製剤及びその製造方法に関する。 さらに詳しくは、 健康 な烏骨鶏の生体反応を利用して、 個人の生理状態に対応した健康増進効果を発揮 する活性成分を生産させ、 その成分を加工することによって得られたティラーメ ィド製剤及ぴその製造方法に関するものである。  The present invention relates to tiller-made preparations such as health food preparations and pharmaceutical preparations for the purpose of curing chronic diseases such as cancer, diabetes mellitus and allergy and improving symptoms, and to a method for producing the same. The present invention relates to a tiller-made preparation configured to exert a corresponding health promotion effect and a method for producing the same. More specifically, a tiller-med product obtained by using the biological reactions of healthy osseous chickens to produce active ingredients that exert a health-enhancing effect corresponding to the individual's physiological condition, and then processing the ingredients. And its production method.
[背景技術]  [Background technology]
従来の健康食品製剤には、 ビタミン、 ミネラル、 抗酸化物質等の健康増進作用 を有する物質を高含有する食品素材、 又は統計学的に有為な健康増進効果が確認 された天然物からなる食品素材が含有されている。 また、 従来の医薬品製剤には 、 薬理効果を有する薬剤が含有されている。 健康食品製剤及び医薬品製剤は、 そ れを摂取した人に対してある特定の健康増進効果又は薬理効果を発揮する。  Conventional health food preparations include food materials that contain high levels of health-promoting substances such as vitamins, minerals, and antioxidants, or foods made of natural products that have been confirmed to have statistically significant health-promoting effects. Material is contained. Further, conventional pharmaceutical preparations contain a drug having a pharmacological effect. Health food preparations and pharmaceutical preparations exert certain health-enhancing or pharmacological effects on those who take them.
ところが、 従来の健康食品製剤及ぴ医薬品製剤では、 種々の体調不良や慢性疾 患に対して、 期待していた程の改善効果や治療効果が発揮されないケースが多い うえ、 過剰摂取に起因する副作用発生のおそれも高かった。  However, conventional health food preparations and pharmaceutical preparations often fail to achieve the expected improvement and treatment effects for various illnesses and chronic diseases, as well as side effects caused by excessive intake. The risk of occurrence was also high.
[発明の開示]  [Disclosure of the Invention]
本発明の目的は、 副作用なく手軽に摂取することができるうえ、 個人の生理状 態に対応した健康増進効果を容易に奏するティラーメイド製剤及びその製造方法 を提供することにある。  An object of the present invention is to provide a tiller-made preparation which can be easily taken without side effects and easily exerts a health promotion effect corresponding to an individual's physiological condition, and a method for producing the same.
上記の目的を達成するために、 本発明の一態様では、 個人の生理状態に対応し た健康増進効果を発揮するティラーメイド製剤が提供される。 その製剤は、 個人 の生理学的情報の担持体を烏骨鶏に接種し、 所定期間飼育した後の烏骨鶏の肉を In order to achieve the above object, according to one aspect of the present invention, there is provided a tiller-made preparation exhibiting a health promotion effect corresponding to an individual's physiological condition. The formulation inoculates a carrier of the physiological information of the individual into the ostrich chicken, and after breeding for a predetermined period, the meat of the ostrich chicken.
5 0 °C以下で乾燥及ぴ破砕することによって得られた、 個人の生理状態が反映さ れた烏骨鶏の乾燥肉を含有する。 Contains dried meat of osseous chicken, which reflects the physiological condition of the individual, obtained by drying and crushing at 50 ° C or less.
担持体は烏骨鶏に経皮又は経口投与により接種される、 個人の血清及ぴ尿のい ずれか一つであることが好ましい。 一態様では、 所定期間は 3 0〜7 5日である 。 ティラーメイド製剤は、 成人 1人当たり、 8〜1 2 gの乾燥肉を週 1回、 1 0 週間以上継続して経口摂取されるのが好ましい。 The carrier is used to inoculate osseous chickens transdermally or orally, with individual serum and urine Preferably, there is only one. In one aspect, the predetermined time period is between 30 and 75 days. Preferably, the tiller maid preparation is orally ingested from 8 to 12 g of dry meat once a week for at least 10 weeks per adult.
本発明は更にティラーメイド製剤の製造方法を提供する。 その方法は、 個人の 生理学的情報の担持体を烏骨鶏に接種する工程と、 所定期間飼育した烏骨鶏の肉 を 5 0 °C以下で乾燥及び破砕する工程とを含む。  The present invention further provides a method for producing a tiller-made preparation. The method includes a step of inoculating a carrier of physiological information of an individual into a ostrich, and a step of drying and crushing the meat of the ostrich bred for a predetermined period of time at 50 ° C or less.
[図面の簡単な説明]  [Brief description of drawings]
図 1は本発明のティラーメイド製剤を服用した男性 Aの空腹時血糖値の変化を 示すグラフ。  FIG. 1 is a graph showing the change in fasting blood glucose level of male A who took the tiller maid preparation of the present invention.
[発明を実施するための最良の形態]  [Best Mode for Carrying Out the Invention]
本願発明者は、 烏骨鶏を用いて製造したティラーメイ ド製剤が顕著な薬理作用 を奏することを見出し、 本願発明を完成した。  The inventor of the present application has found that a tiller-made preparation produced using a crow bone chicken has a remarkable pharmacological action, and has completed the present invention.
はじめに、 烏骨鶏について説明する。  First, I will explain the osseous chicken.
烏骨鶏は一般的な鶏よりもやや小型の品種である。 烏骨鶏は全身がシルクのよ うな細く柔らかい羽毛で覆われる。 烏骨鶏の顔、 皮膚、 肉、 骨、 内臓は黒紫色で ある。 耳朶はコバルトブルーである。 雄の頭部にはクルミ冠があり、 雌は立派な 毛冠を有する。 烏骨鶏は、 中国の古い文献に不老長寿の薬として、 或いは病気治 療ゃ美容健康のための宮廷薬膳料理として記載されている。 烏骨鶏は、 自然淘汰 に耐えられない種であるにもかかわらず、 優れた薬効を有するため、 数千年もの 期間に渡って種が保存され、 多くの人々に愛され続けてきた。 現在では、 烏骨鶏 は抗癌作用等の種々の薬理作用があることが知られており、 漢方薬の原料として 利用される。 しかしながら、 烏骨鶏の薬理作用は詳しく研究されていない。  Cousin chickens are slightly smaller varieties than common chickens. The whole body of the ostrich is covered with silky, thin and soft feathers. The face, skin, meat, bones, and internal organs of the crow bone chicken are dark purple. The earlobe is cobalt blue. The male has a walnut crown on the head, and the female has a fine crown. Cousin chicken is described in old Chinese literature as a medicine for longevity or as a court meal for treating illness and beauty. Despite being a species that cannot withstand natural selection, crow's-bone chickens have been preserved for thousands of years because of their excellent medicinal properties, and have been loved by many people. At present, crow bone chicken is known to have various pharmacological actions such as anticancer action, and is used as a raw material for herbal medicine. However, the pharmacological effects of osseous chicken have not been studied in detail.
以下、 一実施形態のティラーメイド製剤について説明する。  Hereinafter, the tiller-made preparation of one embodiment will be described.
ティラーメイド製剤には、 特定の個人の生理状態 (病理状態) を反映した烏骨 鶏の乾燥肉が含有されている。 ティラーメイ ド製剤は、 その個人の生理状態又は 病理状態に対応した健康増進効果又は治癒効果を発揮する。 ティラーメイド製剤 は、 特定の個人のためだけに製造及び利用される健康食品製剤又は医薬品製剤で ある。 即ち、 ティラーメイド製剤は、 特定の個人が自分専用の製剤の製造を製造 業者に委託 ·注文し、 その注文に基づいて製造業者が製造してその人に提供する オーダーメイド製品である。 Tillermaid preparations contain dried meat of crow bone chicken that reflects the physiological condition (pathological condition) of a particular individual. Tillermade preparations exert a health-promoting or healing effect corresponding to the physiological or pathological condition of the individual. Tiller-made products are health food or pharmaceutical products that are manufactured and used exclusively for a particular individual. That is, a tailor-made product is entrusted and ordered by a specific individual to a manufacturer for the manufacture of a personalized product, and the manufacturer manufactures the product based on the order and provides it to that person. It is a custom-made product.
烏骨鶏の乾燥肉は次のようにして得られる。 まず、 特定の個人の生理学的情報 の担持体を烏骨鶏の生体内に接種し、 所定期間飼育する。 烏骨鶏を屠殺し、 その 肉を 5 0 °C以下の温度で乾燥及び破碎 (粉砕) することによって乾燥粉末又は経 口摂取しやすい大きさの粒状物が得られる。 なお、 烏骨鶏の肉としては、 モモ肉 、 ムネ肉及ぴササミ肉からなる群から選ばれる少なくとも 1種が好適である。 テ イラーメイド製剤としては、 粉末状の烏骨鶏の乾燥肉そのもの、 或いはその乾燥 肉を常法に従って加工した錠剤、 カプセル剤、 ドリンク剤等の経口摂取可能な形 態であってもよい。  The dried meat of the crow bone chicken is obtained as follows. First, a carrier of physiological information of a specific individual is inoculated into a living body of a crow bone chicken and bred for a predetermined period. By slaughtering the ostrich chicken, the meat is dried and crushed (crushed) at a temperature of 50 ° C or less to obtain a dry powder or a granular material that can be easily ingested. In addition, as the meat of the crow bone chicken, at least one selected from the group consisting of peach meat, breast meat, and fillet meat is preferable. The tailor-made preparation may be in the form of powdered dry meat of osseous chicken itself or in a form that can be orally ingested such as tablets, capsules and drinks prepared by processing the dried meat according to a conventional method.
特定の個人の生理学的情報の担持体としては、 その個人の生理状態に関する情 報が担持された身体 (組織) の一部、 分泌物又は排泄物が挙げられる。 好ましい 担持体は、 健康状態に関する生理学的情報がより多く担持されているうえ採取し やすいことから、 血清又は尿である。 担持体には、 その個人の生理状態 (病理状 態) に関する情報が、 例えば、 免疫グロブリン (抗体) 、 クラス I又はクラス I I ヒ ト白血球抗原 (H L A ) と結合した非自己抗原、 毒素、 或いは適量でないホル モン、 血清コレステロール、 中性脂肪、 血糖、 G O T (glutamate oxaloacetat e transaminase) 、 G P ^glutamate pyruvate transaminase) 、 γ— G T P (glutamyl transpept i dase) 、 尿蛋白、 尿潜血、 尿糠、 ゥロビリノ一ゲン等の 種々の形態にて盛り込まれている。 なお、 担持体の採取は、 個人の生理状態 (病 理状態) を正確にティラーメイド製剤に反映させるために、 過労、 睡眠不足、 二 日酔い等のストレス状態を避け、 体調の良いときに行うのが好ましい。  Carriers of physiological information of a particular individual include parts of the body (tissue), secretions or excretions carrying information on the physiological condition of that individual. Preferred carriers are serum or urine because they carry more physiological information about their health and are easier to collect. The carrier contains information about the individual's physiological condition (pathology), such as immunoglobulins (antibodies), non-self antigens bound to class I or class II human leukocyte antigen (HLA), toxins, or appropriate amounts. Non-hormones, serum cholesterol, neutral fat, blood sugar, GOT (glutamate oxaloacetat e transaminase), GP ^ glutamate pyruvate transaminase), γ-GTP (glutamyl transpeptidase), urinary protein, urinary occult blood, urinary bran, urobilinogen Etc. are included in various forms. In order to accurately reflect the physiological condition (disease state) of the individual in the tiller maid preparation, the carrier should be collected when the patient is in good physical condition, avoiding stress such as overwork, lack of sleep, and hangover. Is preferred.
担持体は、 生後 1 8 0日齢以上の成体烏骨鶏に接種するのが好ましく、 生後 1 8 0〜3 0 0日齢の生体反応が盛んな壮年期の烏骨鶏に接種するのがより好まし い。 雌雄は問われない。 さらに、 、 担持体に担持されている生理学的情報を鋭敏 かつ漏れなく反映させるために、 ス トレスを極力低減させた環境で健康に飼育さ れた烏骨鶏に接種するのが好ましい。 ス トレスを低減させた環境としては、 例え ば、 無農薬で抗生物質やサルファ剤を含まない有機飼料や水を与えた環境、 アル ギン酸ゃョードを高含有する海藻を食餌に与えた環境、 或いは環境汚染や騒音、 他種生物による干渉の少ない環境が挙げられる。 また、 雑種ではなく純系の烏骨 鶏が好ましい。 The carrier is preferably inoculated into adult ostrich chickens at the age of 180 days or older, and inoculated into middle-aged ostrich chickens at the age of 180 to 300 days after birth, where biological reactions are active. More preferred. Sex is not asked. Furthermore, in order to reflect the physiological information carried on the carrier sharply and without omission, it is preferable to inoculate healthy breeding chickens in an environment in which stress is minimized. Environments with reduced stress include, for example, an environment where organic feed and water are provided without pesticides and without antibiotics or sulfa drugs, an environment where seaweed containing high alginate is fed, or Environments with low environmental pollution, noise, and interference from other species. Also, pure crow bones, not hybrids Chicken is preferred.
担持体を烏骨鶏に接種する際には、 簡便であるうえ烏骨鶏の健康状態に影響を 与えにくいことから、 経皮投与又は経口投与が採用される。 経皮投与により血清 等を接種する際には、 静脈注射又は胸部への筋肉注射が最も効果的であり、 この 場合には、 通常、 烏骨鶏 1羽につき血清約 l m 1が 1〜2回程度 (2回注射する 際には 1週間程間隔をあける) 注射される。 また、 経口投与により尿等を接種す る際には、 通常、 烏骨鶏 1羽につき 5 m l程度の尿を 1週間毎に 5〜 7回程度強 制的又は自発的に経口投与する。  When the carrier is inoculated into ostriches, dermal or oral administration is adopted because it is simple and does not easily affect the health of ostriches. When serum is inoculated by dermal administration, intravenous injection or intramuscular injection into the chest is most effective.In this case, usually about 1 to 2 serum lm1 per bird is used. Degree (at the interval of about one week when injecting twice) Injected. When inoculating urine or the like by oral administration, usually about 5 ml of urine per bird is forcibly or spontaneously administered about 5 to 7 times a week.
担持体を烏骨鶏に接種してから屠殺するまでの飼育期間は、 接種開始後 (第 1 · 回目の接種を開始してから) 好ましくは 3 0〜 7 5日、 より好ましくは 3 5〜 7 0日、 さらに好ましくは 3 5〜6 0日である。 飼育期間が 3 0日未満の場合には 、 烏骨鶏の生体内で特定の個人の生理状態 (病理状態) を反映した健康増進効果 を有する活性成分 (おそらくは抗体様の物質であると考えられる) が十分に生産 されないおそれがある。 逆に 7 5日を越える場合には、 活性成分量が大幅に低減 されるおそれがある。 経口投与により接種する場合には、 全ての接種が終了する までに長い期間を要することから、 飼育期間は 9 0日程度まで延長してもよい。 この場合、 良好なティラーメイド製剤が得られる可能性がある。  The breeding period from inoculation of the carrier to the osseous chicken to slaughter is preferably 30 to 75 days after the start of the inoculation (from the start of the first inoculation), more preferably 35 to 75 days. 70 days, more preferably 35 to 60 days. If the breeding period is less than 30 days, the active ingredient having a health-promoting effect that reflects the physiological state (pathological state) of a specific individual in the living body of the crow bone chicken (probably an antibody-like substance ) May not be produced sufficiently. On the other hand, if it exceeds 75 days, the amount of the active ingredient may be significantly reduced. In the case of inoculation by oral administration, the breeding period may be extended to about 90 days because it takes a long time to complete all inoculations. In this case, a good tailor-made product may be obtained.
屠殺後の烏骨鶏から採取された肉は、 乾燥及び破砕して粉末状又は粒状の烏骨 鶏の乾燥肉へと加工されるが、 経口摂取しやすいことから粉末状に粉砕するのが 好ましい。 なお、 乾燥及び破砕時には、 健康増進効果を有する活性成分の変性及 ぴ失活を防止するために、 全ての工程が 5 0 °C以下の温度で行われる必要があり 、 蛋白の変性を効果的に抑えるために 4 0 °C以下の温度で行われるのが好ましい 。 また、 乾燥工程としては、 活性成分の変性及ぴ失活をより一層効果的に抑える ために、 凍結乾燥 (フリーズドライ) 法により行われるのが好ましい。  Meat collected from slaughtered poultry chicken is dried and crushed to be processed into powdered or granular dried poultry meat of poultry chicken. . At the time of drying and crushing, in order to prevent denaturation and deactivation of the active ingredient having a health-promoting effect, all the steps must be carried out at a temperature of 50 ° C or less, and the denaturation of the protein is effective. It is preferable that the heating is performed at a temperature of 40 ° C. or less in order to suppress the temperature to 40 ° C. In addition, the drying step is preferably performed by a freeze-drying (freeze-drying) method in order to more effectively suppress denaturation and deactivation of the active ingredient.
ティラーメイ ド製剤の作用について以下に記載する。  The effects of the tillermade preparation are described below.
ティラーメイ ド製剤を製造する際には、 まず、 1 8 0日齢以上の健康な烏骨鶏 を 2 ~ 3羽用意する。 注文主から採取した生理学的情報の担持体を各烏骨鶏に接 種し、 それら烏骨鶏を所定の飼育期間ス トレスを低減させた環境で健康状態を継 続的に維持しながら飼育した後に屠殺する。 屠殺した烏骨鶏のモモ、 ムネ及ぴサ サミ肉を衛生的に採取し、 5 0 °Cを越えない温度で乾燥させる。 乾燥した肉を破 砕機又は粉砕機にて破砕又は粉砕することによって烏骨鶏の乾燥肉片を調製する 烏骨鶏の乾燥肉片は、 冷蔵庫又は冷凍庫内で衛生的に保管され、 ティラーメイ ド製剤として注文主により適時経口摂取される。 或いは、 乾燥肉片は錠剤、 カブ セル剤、 ドリンク剤等の諸形態に加工されて、 好ましくは冷蔵庫又は冷凍庫内で 保管され、 ティラーメイド製剤として注文主により適時経口摂取される。 なお、 ティラーメイ ド製斉 [)は、 成人 1人当たり、 烏骨鶏の乾燥肉 1 0 g前後 (8〜1 2 g ) を週 1回 (好ましくは 7日毎に) 経口摂取される。 好ましくは 1 0週間以上 、 より好ましくは 1 0〜2 0週間継続して摂取されるのが最も好ましい。 When manufacturing a tillermade preparation, first, prepare two or three healthy ostrich chickens that are at least 180 days old. Carriers of physiological information collected from the orderer were bred to each ostrich, and the ostrich were bred while maintaining their health in an environment with reduced stress for a given breeding period. Slaughter later. Peach, mune and sasa of slaughtered chicken Sanitary meat is collected and dried at a temperature not exceeding 50 ° C. Prepare dried meat pieces of crow bone chicken by crushing or crushing the dried meat with a crusher or crusher.The dried meat pieces of crow bone chicken are stored hygienically in a refrigerator or freezer and ordered as tiller-made products. It is taken orally mainly by the patient. Alternatively, the dried meat pieces are processed into various forms such as tablets, capsules, drinks and the like, preferably stored in a refrigerator or a freezer, and orally ingested by the client as a tiller-made preparation at appropriate times. In addition, Tillermaid Seika [) is orally ingested about 10 g (8 to 12 g) of dry meat of crow bone chicken once a week (preferably every 7 days) per adult. It is most preferably taken for 10 weeks or more, more preferably for 10 to 20 weeks continuously.
ティラーメイド製剤は、 特定の病気の治癒や症状の改善を目的として服用する 場合には、 その病気や症状の元を構成している臓器又は組織内の細胞の平均的な 入れ替わりサイクル (生理的な細胞寿命) に相当する期間、 又はその整数倍の期 間継続して服用されるのが好ましい。 例えば、 糖尿病を罹患している場合には、 腌臓のィンシュリン産生細胞の平均的な細胞寿命に相当する期間継続して服用す るとよく、 その細胞寿命の 2倍の期間継続して服用するのがより好ましい。  When taken for the purpose of healing or ameliorating the symptoms of a specific disease, the Tiller Made preparation is used for the average replacement cycle of the cells in the organs or tissues that make up the disease or condition (physiological changes). It is preferable to take the drug continuously for a period corresponding to (cell life) or an integral multiple thereof. For example, if you have diabetes, you should take it continuously for a period corresponding to the average cell life of the insulin-producing cells of the kidney, and you should take it for twice the life of the cell Is more preferred.
一実施形態によれば、 以下の利点が得られる。  According to one embodiment, the following advantages are obtained.
• ティラーメイド製剤は、 特定の個人の生理状態が反映された烏骨鶏の乾燥 肉を含有する。 烏骨鶏の乾燥肉は、 特定の個人の生理学的情報の担持体を健康な 烏骨鶏に健康を害さないように接種し、 烏骨鶏を健康に維持しながら所定期間飼 育した後に屠殺し、 その生肉を 5 0 °C以下の温度で乾燥及び破砕することによつ て得られる。 ティラーメイド製剤は、 健康な烏骨鶏の肉を原料としていることか ら、 手軽に摂取することができるうえ、 摂取しすぎても薬害等の副作用が生じる おそれがない。  • Tillermaid preparations contain dried meat from ostrich chicken that reflects the physiological condition of a particular individual. Dried meat of the ostrich chicken is inoculated with a carrier of physiological information of a specific individual to a healthy ostrich chicken so as not to harm the health, and slaughtered after bred for a predetermined period while maintaining the health of the ostrich chicken. It is obtained by drying and crushing the raw meat at a temperature of 50 ° C or less. Tiller-made preparations can be easily ingested because they are made from healthy bovine chicken meat, and there is no risk of side effects such as phytotoxicity if ingested too much.
烏骨鶏の乾燥肉は、 古くから多くの実例に裏付けられた、 万人に効く薬理作用 を持つ上、 健康な烏骨鶏の生体反応を利用して特別に生産させた特定個人用の活 性成分を含有する。 このため、 ティラーメイド製剤は、 特定の個人に対して健康 増進作用の相乗効果を発揮することができる。 また、 ティラーメイド製剤は、 蛋 白及びアミノ酸を高濃度で含有していることから、 新陳代謝を活発化させる等の 健康増進作用をも発揮することができる。 Dried meat of ostrich chicken has a long-lasting, pharmacological action that is effective for everyone and has been specially produced using the biological reactions of healthy ostrich chicken. Contains sexual components. For this reason, the Tillermaid formulation can exert a synergistic effect of promoting health on specific individuals. In addition, tiller maid preparations contain high concentrations of proteins and amino acids, so that metabolism is activated. It can also exert a health promotion effect.
加えて、 活性成分は、 特定の個人の生理学的情報の担持体に基づいて個別生産 されたものであることから、 同個人の生理状態が細微に至るまで反映されており 、 その人の生理状態に対応した健康増進効果を発揮することができる。 担持体に 担持されている生理学的情報は、 ほとんどの場合複数種類存在し多面的 (包括的 ) であることから、 ティラーメイド製剤により多面的な健康増進効果が得られる 。 特定の個人が慢性疾患等の病気に罹患している場合には、 担持体にはその人の 病理状態に関する生理学的情報が盛り込まれることとなり、 その病気に対する顕 著な治癒効果又は症状の改善効果を発揮することができる。  In addition, since the active ingredient is produced individually based on the carrier of the physiological information of a specific individual, the physiological condition of the individual is reflected to the smallest detail, and the physiological condition of the person The health promotion effect corresponding to can be exhibited. In most cases, multiple types of physiological information are carried on the carrier and are multifaceted (comprehensive). Therefore, a multifaceted health-promoting effect can be obtained with the Tillermade formulation. If a specific individual is suffering from a disease such as a chronic disease, the carrier will contain physiological information about the person's pathological condition, and will have a significant healing effect or improvement effect on the disease. Can be demonstrated.
一方、 従来の健康食品製剤及び医薬品製剤では、 各製剤により発揮される効能 は通常 1種類であり、 例えばアレルギー症状の改善に効く製剤は、 ほとんど全て の場合、 癌や糖尿病その他の疾患の改善効果を同時に発揮することはない。 この ため、 これらの製剤を摂取する場合には、 各個人に真に必要とされる効能を明確 化し、 それに基づいて摂取する必要があった。 この場合、 自覚症状や診察等によ り各個人の生理状態 (病理状態) に対応した製剤の選択及び摂取量の決定が行わ れる必要があるが、 実際にはこれら生理状態の診断には人為的な見落としが発生 しゃすかった。 このため、 適切な製剤の摂取が行われない場合が多く、 期待して いた程の改善効果や治療効果が発揮されないケースが多いうえ、 過剰摂取に起因 する副作用発生のおそれも高かった。 これに対し、 本実施形態のティラーメイド 製剤は、 従来の健康食品製剤及び医薬品製剤のような単一の症状の改善効果に止 まらず、 複数の症状に対する多面的な改善効果が発揮される万能薬としての優れ た効能を発揮することができる。  On the other hand, conventional health food preparations and pharmaceutical preparations usually show only one effect of each preparation.For example, almost all preparations that are effective in improving allergic symptoms are effective in improving cancer, diabetes and other diseases. Are not exhibited at the same time. Therefore, when taking these products, it was necessary to clarify the effects that were really needed for each individual and to take them based on them. In this case, it is necessary to select the preparation and determine the intake amount corresponding to the physiological condition (pathological condition) of each individual based on subjective symptoms and medical examinations. Oversight occurred. As a result, in many cases, the ingestion of an appropriate formulation was not performed, and in many cases, the expected improvement and therapeutic effects were not achieved. In addition, there was a high risk of side effects caused by excessive intake. On the other hand, the tiller-made preparation of the present embodiment is not limited to the effect of improving a single symptom as in conventional health food preparations and pharmaceutical preparations, and exhibits a multifaceted improvement effect for a plurality of symptoms. It can exhibit excellent efficacy as a panacea.
• ティラーメイド製剤は、 特定の個人の血清又は尿を烏骨鶏に接種すること によつて製造されることから、 特定の個人の生理状態に対応する多面的な健康増 進効果を容易かつ確実に得ることができる。 即ち、 血清及び尿は、 いずれも健康 診断において医学的に検出される疾患の種類が多いという事実に裏打ちされてい るように、 その個人の生理状態及ぴ病理状態に関する生理学的情報が詳細かつ的 確に盛り込まれたものである。 このため、 これら有用な生理学的情報を担持した 担持体を用いて烏骨鶏の乾燥肉を製造することにより、 その個人の健康状態及び 病理状態の改善に対する極めて多面的かつ的確な効果を得ることが容易となる。• Tiller-made products are manufactured by inoculating the serum or urine of a specific individual into bovine hens, so that a multifaceted health promotion effect corresponding to the physiological condition of a specific individual is easily and reliably achieved. Can be obtained. In other words, serum and urine provide detailed and detailed physiological information on the physiological and pathological states of the individual, as evidenced by the fact that there are many types of diseases that are medically detected in medical examinations. It is definitely included. For this reason, by producing dried meat of ostrich chicken using such a carrier carrying useful physiological information, the health condition of the individual and the It is easy to obtain an extremely multifaceted and accurate effect on the improvement of the pathological condition.
- 個人の生理学的情報の担持体を接種してから 3 0〜7 5日間烏骨鶏を飼育 した後に肉を採取することによって、 極めて高い健康増進効果を発揮するティラ 一メイド製剤を得ることができる。 即ち、 免疫反応に代表される生体防御反応は 、 反応の開始から 3 0〜7 5日をピークに最大の活性を示すようになっており、 ピークにある状態の烏骨鶏肉を採取して利用することにより、 最大の健康増進効 果を著しく容易に得ることが可能となる。 さらに、 活性が失われる前に乾燥させ ることによって、 同活性成分に対する物理化学的及び生物学的影響を最小限に低 減させることができることから、 活性成分の活性を長期間に渡って継続的に保持 させるのが容易となる。 -Breeding chickens for 30 to 75 days after inoculating the carrier with the physiological information of the individual, and then collecting the meat to obtain a Tila one-made product that exhibits an extremely high health promotion effect. it can. That is, the biological defense reaction represented by the immune reaction shows the maximum activity at the peak 30 to 75 days from the start of the reaction, and the bovine chicken in the peak state is collected and used. By doing so, it is possible to obtain the maximum health promotion effect significantly easily. Furthermore, by drying before the activity is lost, the physicochemical and biological effects on the active ingredient can be minimized, so that the activity of the active ingredient can be continuously maintained for a long period of time. This makes it easier to hold them.
• ティラーメイ ド製剤は、 成人 1人当たり、 烏骨鶏の乾燥肉 8〜1 2 gを週 1回経口摂取するとともに、 1 0週間以上継続して摂取するように構成されてい ることから、 健康増進効果を著しく容易に高めることができる。 ティラーメイド 製剤の摂取方法は、 生理学的情報の担持体を烏骨鶏に経口投与したときと同様に 、 投与された個体の生体反応を最も効率的かつ積極的に引き出すことができる方 法であることから、 健康増進効果を高めるうえでは最適である。  • Tillermade products are designed to take 8 to 12 g of dry meat of crow boned chicken once per week per adult, and to be taken continuously for at least 10 weeks, thereby promoting health. The effect can be significantly increased. The method of ingesting the tiller maid preparation is the most efficient and aggressive way to elicit the biological response of the administered individual, similar to when the carrier of the physiological information is orally administered to the ostrich. Therefore, it is optimal for enhancing health promotion effects.
以下、 本発明のより具体的な実施例について説明する。  Hereinafter, more specific examples of the present invention will be described.
(実施例 1 )  (Example 1)
軽度の成人型糖尿病と軽度の慢性ァレルギ一性皮膚炎とを患っている日本人男 性 A ( 5 9歳、 体重 6 0 k g ) の血清を採取した。 男性 Aの空腹時血糖値は、 数 年来継続して 1 5 0〜2 0 O m g / d 1程度で推移していた。 男性 Aは、 試験前 及び試験中には朝夕食事前に 6単位のィンシュリンを服用し、 オイダルコン (Eu glucon :製品名) 2 . 5 m g錠を朝食後に 2錠、 夕食後に 1錠服用していた。 ストレスを低減させた環境で飼育した 1 8 0〜 2 5 0日齢の健康な烏骨鶏 3羽 に、 1 m 1の血清を静脈注射した。 3 0日経過した後に 3羽の烏骨鶏を屠殺し、 モモ、 ムネ及びササミ肉を衛生的に採取した。 採取した生肉をミンチにした後に 凍結乾燥機にて凍結乾燥した。 凍結乾燥された烏骨鶏肉を、 フードプロセッサに て 5 0 °C以下で注意深く粉砕した。 粉碎された肉片を 1 0 gずつ袋詰めすること によって、 ティラーメイド製剤を製造した。 ティラーメイド製剤は冷凍庫内で保 管された。 男性 Aは週 1回 1袋のティラーメイド製剤を継続的に経口摂取した。 男性 Aの空腹時血糖値を毎日測定して週平均値 (投与開始 1週目以前は月平均値 ) を求めた。 図 1に示すように、 男性 Aの血糖値は、 時間経過とともに着実に低 下し、 空腹時血糖値は 1 0週目には 1 1 O m g / d 1、 1 1週目には 1 1 2 m g Z d l、 1 2週目には 1 0 2 m g Z d 1であった。 アレルギー性皮膚炎に関して は、 男性 Aの自覚症状が徐々に、 かつ、 明確に沈静化した。 また、 男性 Aは身体 の疲労の低下を実感した。 Serum from a Japanese male A (59 years old, weighing 60 kg) suffering from mild adult-type diabetes and mild chronic allergic monodermatitis was collected. The fasting blood glucose level of Male A has been around 150 to 20 Omg / d1 continuously for several years. Male A took 6 units of insulin before and during the test before and during the test, and took 2.5 mg eudalcon (Eu glucon: product name) 2.5 mg tablets after breakfast and 1 tablet after dinner . Three 180- to 250-day-old healthy ostrich chickens kept in a stress-reduced environment were injected intravenously with 1 ml of serum. After 30 days, three hens were slaughtered and peaches, mune and fillet were collected in a sanitary manner. The minced raw meat was freeze-dried with a freeze dryer. The lyophilized chicken was carefully ground in a food processor at 50 ° C or less. Tiller-made preparations were manufactured by bagging 10 g of the ground meat pieces. Keep the tiller maid product in the freezer Was tubed. Male A continuously ingested one bag of tillermaid once a week. The fasting blood glucose level of male A was measured daily to determine the weekly average (monthly average before the first week of administration). As shown in Figure 1, the blood glucose level of male A declined steadily over time, with fasting blood glucose levels of 11 Omg / d1 at week 10 and 11 at week 11. The dose was 2 mg Zdl and at week 12 was 102 mg Zd1. With regard to allergic dermatitis, subjective symptoms of Male A gradually and clearly subsided. Male A also felt reduced physical fatigue.
なお、 一実施形態は、 次のように変更してもよい。  In addition, one embodiment may be changed as follows.
• 特定の個人の血清を烏骨鶏に経皮投与するとともに、 同時又は異なるタイ ミングで同個人の尿を烏骨鶏に経口投与してもよい。 この場合、 特定の個人の生 理状態 (病理状態) に対するより多面的な健康増進効果を発揮するティラーメイ ド製剤を製造することが可能となる。  • While the serum of a particular individual may be transdermally administered to the ostrich, the urine of the same individual may be orally administered to the ostrich at the same time or at a different time. In this case, it is possible to manufacture a tiller-made preparation that exerts a more versatile health promotion effect on the physiological state (pathological state) of a specific individual.
• 生理学的情報の担持体として血液を用いてもよい。 この場合には、 血球系 又は血液凝固系の疾患に対する治癒効果が発揮され得る。  • Blood may be used as a carrier for physiological information. In this case, a healing effect on diseases of blood cells or blood coagulation can be exerted.
• 血清又は尿中から特定の成分 (免疫グロブリン画分等) を分離 ·精製し、 その分離された成分のみを烏骨鶏に接種してもよい。 或いは、 生検により採取さ れた身体組織 (癌細胞等) を生理学的情報の担持体として用いてもよい。 これら 場合、 生理学的情報の担持体を予め絞り込むことによって、 目的とする疾患に関 する高度に特異的な治癒効果を発揮させることができる。  • A specific component (immunoglobulin fraction, etc.) may be separated and purified from serum or urine, and only the separated component may be inoculated into ostriches. Alternatively, a body tissue (cancer cell or the like) collected by a biopsy may be used as a carrier for physiological information. In these cases, a highly specific healing effect on the target disease can be exerted by narrowing down the carriers of the physiological information in advance.
• ティラーメイ ド製剤中に、 烏骨鶏の乾燥肉以外にも、 同烏骨鶏由来の各種 成分 (例えば、 卵 (卵黄、 卵白、 卵殻、 卵殻膜) 、 内臓 (心臓や肝臓) 、 表皮、 骨、 血液、 鶏冠等) を乾燥させた乾燥物を含有させてもよい。 なお、 乾燥物は、 5 0 °C以下で乾燥及び粉砕することによって製造されるのが好ましい。  • In the tiller maid preparation, in addition to the dried meat of the osseous chicken, various components derived from the osseous chicken (eg, eggs (egg yolk, egg white, eggshell, eggshell membranes), internal organs (heart and liver), epidermis, bone , Blood, cockscomb, etc.). The dried product is preferably manufactured by drying and pulverizing at 50 ° C. or lower.

Claims

請求の範囲 The scope of the claims
1 . 個人の生理状態に対応した健康増進効果を発揮するティラーメイ ド製剤であ つて、 1. A tiller-made preparation that exerts health-promoting effects corresponding to the individual's physiological condition.
個人の生理学的情報の担持体を烏骨鶏に接種し、 所定期間飼育した後の烏骨鶏 の肉を 5 0 °C以下で乾燥及び破碎することによって得られた、 個人の生理状態が 反映された烏骨鶏の乾燥肉を含有するティラーメイド製剤。  Reflects the physiological condition of the individual obtained by inoculating a carrier of the physiological information of the individual into the ostrich and drying and crushing the meat of the ostrich after breeding for a specified period of time at 50 ° C or less. Tiller-made preparation containing dried meat of dried ostrich chicken.
2 . 前記担持体は、 前記烏骨鶏に経皮又は経口投与により接種される、 個人の血 清及ぴ尿のいずれか一つであることを特徴とする請求の範囲第 1項に記載のティ ラーメイド製剤。 2. The carrier according to claim 1, wherein the carrier is one of an individual's serum and urine, which is inoculated into the osseous chicken by transdermal or oral administration. Tiller-made preparation.
3 . 所定期間は 3 0〜7 5日であることを特徴とする請求の範囲 1又は請求の範 囲第 2項に記載のティラーメイド製剤。 3. The tiller-made preparation according to claim 1 or claim 2, wherein the predetermined period is 30 to 75 days.
4 . 成人 1人当たり、 8〜1 2 gの前記乾燥肉を週 1回、 1 0週間以上継続して 経口摂取されることを特徴とする請求の範囲第 1項乃至第 3項のいずれか一つに 記載のティラーメイド製剤。 4. The method according to any one of claims 1 to 3, wherein 8 to 12 g of the dried meat is orally ingested once per week for at least 10 weeks per adult. The tiller-made preparation described in the above.
5 . 請求の範囲第 1項乃至第 4項のいずれか一つに記載のティラーメイ ド製剤の 製造方法であって、 5. A method for producing a tillermade preparation according to any one of claims 1 to 4, wherein
個人の生理学的情報の担持体を烏骨鶏に接種する工程と、  Inoculating the carrier of the physiological information of the individual to the crow bone chicken;
所定期間飼育した烏骨鶏の肉を 5 0 °C以下で乾燥及び破砕する工程とを含むこ とを特徴とするティラーメイド製剤の製造方法。 O 03/105873 Drying and crushing the meat of the ostrich chicken raised at a predetermined temperature of 50 ° C or less for a predetermined period of time. O 03/105873
Fig.1 Fig.1
Figure imgf000012_0001
Figure imgf000012_0001
> > 、ο 、'  >>, Ο, '
投与後の経過日数 (週)  Days after administration (weeks)
PCT/JP2002/005901 2002-06-13 2002-06-13 Tailor-made preparation and process for producing the same WO2003105873A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002313212A AU2002313212A1 (en) 2002-06-13 2002-06-13 Tailor-made preparation and process for producing the same
PCT/JP2002/005901 WO2003105873A1 (en) 2002-06-13 2002-06-13 Tailor-made preparation and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/005901 WO2003105873A1 (en) 2002-06-13 2002-06-13 Tailor-made preparation and process for producing the same

Publications (1)

Publication Number Publication Date
WO2003105873A1 true WO2003105873A1 (en) 2003-12-24

Family

ID=29727349

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/005901 WO2003105873A1 (en) 2002-06-13 2002-06-13 Tailor-made preparation and process for producing the same

Country Status (2)

Country Link
AU (1) AU2002313212A1 (en)
WO (1) WO2003105873A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225254A2 (en) * 1985-11-25 1987-06-10 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
JPH0587815A (en) * 1991-02-08 1993-04-06 Taiyo Kagaku Co Ltd Antiblood plasma type glutathione peroxidase antibody and diagnostic medicine using it
JPH05252909A (en) * 1991-02-22 1993-10-05 Yoshio Murai Production of silky fowl blood meal
JPH06329700A (en) * 1993-05-19 1994-11-29 Taiyo Kagaku Co Ltd Production of specific hen's egg antibody
JPH08259462A (en) * 1994-12-05 1996-10-08 Adtec Kk Antiparbovirus infectious disease composition
WO1998014209A1 (en) * 1996-10-02 1998-04-09 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225254A2 (en) * 1985-11-25 1987-06-10 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
JPH0587815A (en) * 1991-02-08 1993-04-06 Taiyo Kagaku Co Ltd Antiblood plasma type glutathione peroxidase antibody and diagnostic medicine using it
JPH05252909A (en) * 1991-02-22 1993-10-05 Yoshio Murai Production of silky fowl blood meal
JPH06329700A (en) * 1993-05-19 1994-11-29 Taiyo Kagaku Co Ltd Production of specific hen's egg antibody
JPH08259462A (en) * 1994-12-05 1996-10-08 Adtec Kk Antiparbovirus infectious disease composition
WO1998014209A1 (en) * 1996-10-02 1998-04-09 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KANEYOSHI AKAMATSU, 15 October 1980, ISHIYAKU PUB., INC., article "New revision Wakan'yaku", pages: 824 - 829, XP002971367 *

Also Published As

Publication number Publication date
AU2002313212A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
JP7281031B2 (en) Composition for ameliorating persistent attention deficit associated with aging
JP4132635B2 (en) Uninactivated enzyme-enhanced composition
CN103829230A (en) Health product having anti-fatigue effect and preparation method thereof
RU2585049C2 (en) Preparation from eggs with regenerative, analgesic and anti-inflammatory properties
CN113413454A (en) Composition for promoting gastric mucosa injury repair and preparation method thereof
CN109069532A (en) Composition containing chromium is for improving health and body-building
Kellogg Autointoxication; Or, Intestinal Toxemia
Knefeli et al. Improved wound healing after oral application of specific bioactive collagen peptides
Hopkins Report on the Present State of Knowledge Concerning Accessory Food Factors (vitamines).
WO2003105873A1 (en) Tailor-made preparation and process for producing the same
SULLIVAN et al. Nutritional dermatoses in the rat: V. signs and symptoms resulting from a diet containing unheated dried egg white as the source of protein
CN114599358A (en) Sleep improving composition containing ergothioneine or its salt
TW201039839A (en) Composition for regulating antonomic nervous activity and method for regulating autonomic nervous
WO2009115429A1 (en) Food preparation and pharmaceutical composition containing an embryonic extract
RU2147239C1 (en) General tonic nonspecific immunomodulating agent
WO2010119804A1 (en) Anti-mental fatigue agent
JP2001048794A (en) Health food and medicinal composition which contain mixture of powder originated from leaf of mulberry and powder originated from oyster and is used for treating niddm
RU2713935C1 (en) Peptides of marine origin and fish nucleotides, compositions and use thereof for reducing blood glucose
JPH01304861A (en) Production of dried powder of earthworm
CN1072955C (en) Tonic liquid of black ewe's placenta extract and its preparing method
CN108936689A (en) Adjust the oral solution and preparation method thereof of immunity
CN108066363A (en) A kind of nourishing the liver body building composition
Mindell Earl Mindell's Supplement Bible: A Comprehensive Guide to Hundreds of NEW Natural Products that Will Help You Live Longer, Look Better, Stay Heathier, Improve Strength and Vitality, and Much More!
CN113616771A (en) Lyophilized powder of active protein extracted from placenta Cervi, placenta Cervi oral liquid and their preparation methods
RU2117435C1 (en) Food restorative treatment-and-prophylactic additive

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP